|
|
|
|
|
|
|
September 2007 September 28, 2007 NEW YORK (Reuters Health) - A long-term study shows that sexual dysfunction is a major problem that does not fully subside after a type of stem cell therapy called hematopoietic cell transplantation, or HCT. This is true in both men and women. September 25, 2007 BARCELONA/LONDON (Reuters) - Patients with advanced prostate cancer given AstraZeneca's experimental pill ZD4054 live around seven months longer than those on placebo, according to results of a clinical trial presented on Tuesday. September 25, 2007 BARCELONA (Reuters) - New research showing Amgen Inc's colon cancer drug Vectibix only benefits a sub-group of patients may result in more focused use of such therapies for the disease in future, researchers said on Tuesday. September 25, 2007 WASHINGTON (Reuters) - The death rate from breast cancer continues to drop steadily by about 2 percent a year, but black women are not seeing the same benefits as whites, the American Cancer Society said on Tuesday. September 24, 2007 ZURICH (Reuters) - New clinical data showed Avastin improved the chances of a removal of metastatic lesions in patients with colorectal cancer, Swiss drug maker Roche Holding said on Monday. September 24, 2007 BARCELONA (Reuters) - A simple test to measure tumor cells circulating in the blood could make it easier to tell which breast cancer patients are at greatest risk of their cancer returning after treatment, a German researcher said on Monday. September 24, 2007 BARCELONA (Reuters) - Cancer deaths will more than double to 17 million people each year in 2030 with poor countries shouldering the heaviest burden from the disease, the head of the United Nation's cancer agency said on Monday. September 21, 2007 NEW YORK (Reuters Health) - The combination of capecitabine plus trastuzumab is safe and effective for women with heavily pretreated metastatic breast cancer, according to a report in the September 1st issue of the Journal of Clinical Oncology. September 21, 2007 NEW YORK (Reuters Health) - Peripheral blood progenitor cell (PBPC) transplants for severe acquired aplastic anemia are associated with worse outcomes than bone marrow transplants (BMT) in young patients, according to a report in the August 15th issue of Blood. September 21, 2007 NEW YORK (Reuters Health) - Both irinotecan dose and the patient's UGT1A1*28 genotype modulate the risk of irinotecan-induced neutropenia, according to a report in the Journal of the National Cancer Institute for September 5th. Biomarker may identify lung cancer during early asymptomatic stage September 19, 2007 NEW YORK (Reuters Health) - An enzyme that is elevated in malignant tumors may represent a serum biomarker for the early detection of lung cancer, according to a presentation at the International Conference on Molecular Diagnostics in Cancer Therapeutic Development, held this week in Atlanta, Georgia. Bone health of breast cancer patients compromised by long-term chemotherapy September 19, 2007 HONOLULU (Reuters Health) - The bones of breast cancer patients tend to age prematurely as a result of chemotherapy and aromatase inhibitor therapy, and the bone health of these patients should be evaluated as if this were a much older population of women, investigators advised attendees of the annual meeting here of the American Society for Bone and Mineral Research. Fallopian tube often site of malignancies related to BRCA mutations September 19, 2007 NEW YORK (Reuters Health) - In BRCA-positive women undergoing surgery for ovarian cancer risk reduction, the distal fallopian tube appears to be the dominant site of origin of early malignancies, researchers report in the September 1st issue of the Journal of Clinical Oncology. September 17, 2007 NEW YORK (Reuters Health) - Statin heart drugs do not appear to lower the risk of colorectal cancer, new research shows. September 14, 2007 CHICAGO (Reuters) - Eli Lilly & Co said Friday that it had won approval to market its blockbuster osteoporosis drug to post-menopausal women who are at high risk for invasive breast cancer. September 13, 2007 NEW YORK (Reuters Health) - Treating or removing just the part of the prostate that is cancerous may be an effective and less invasive approach for a considerable minority of men with early prostate cancer that is confined to the prostate, according to doctors in Durham, North Carolina. September 11, 2007 NEW YORK (Reuters Health) - Findings from two studies suggest that the previously reported link between finasteride use and high-grade prostate cancer is simply the result of detection bias, not a true causative association. September 11, 2007 NEW YORK (Reuters Health) - Congestive heart failure (CHF) occurs uncommonly during imatinib therapy for hematologic malignancies, according to a report in the August 15th issue of Blood. September 11, 2007 NEW YORK (Reuters Health) - In the 6 months following completion of chemotherapy, women with early-stage breast cancer display greater fatigue than women without a history of cancer, new research shows. The results also suggest that radiotherapy alone has relatively little impact on fatigue. September 11, 2007 WASHINGTON (Reuters) - Vitamin C can impede the growth of some types of tumors although not in the way some scientists had suspected, researchers reported on Monday. Tamoxifen side effects may affect patient adherence September 7, 2007 NEW YORK (Reuters) - Side effects cause many breast cancer patients to stop taking tamoxifen as directed, which, in turn, increases the risk of early death, according to the findings of a new report. September 7, 2007 NEW YORK (Reuters Health) - The outcome of women with familial breast cancer and a BRCA1 mutation is likely to be "unsatisfactory," even when tumors are caught at an apparently early stage through a surveillance program, research indicates. PET/CT reveals occult metastasis of head and neck cancer September 6, 2007 NEW YORK (Reuters Health) - Positron emission tomography-computed tomography using fluorodeoxy-glucose F 18 (FDG-PET/CT) provides early, accurate detection of bone metastases from head and neck squamous cell carcinoma, researchers report in the August issue of Archives of Otolaryngology, Head and Neck Surgery. Teen cancer survivors show mood, behavior problems More vitamin D could mean fewer cancers: study Copyright 2008 Reuters. Click for Restrictions.
|
